These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18241206)

  • 1. Cytomorphology of urothelial carcinomatous peritoneal effusion.
    Xiao GQ
    Cytopathology; 2008 Apr; 19(2):131-3. PubMed ID: 18241206
    [No Abstract]   [Full Text] [Related]  

  • 2. CD138-positive plasmacytoid urothelial carcinoma of the bladder.
    Patriarca C; Di Pasquale M; Giunta P; Bergamaschi F
    Int J Surg Pathol; 2008 Apr; 16(2):215-7. PubMed ID: 18417684
    [No Abstract]   [Full Text] [Related]  

  • 3. High-grade urothelial carcinoma of the urinary bladder showing acquisition of microcystic histology in the penile metastasis: histogenetic considerations.
    Barresi V; Ieni A; Magno C; Barresi G
    Pathol Res Pract; 2009; 205(8):568-71. PubMed ID: 19179016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Leroy X; Gonzalez S; Zini L; Aubert S
    Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
    Sibony M; Billerey C
    Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment on: immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Papatsoris A; Deliveliotis C
    Eur Urol; 2008 May; 53(5):1073. PubMed ID: 17980953
    [No Abstract]   [Full Text] [Related]  

  • 9. Significantly increased accuracy of urothelial carcinoma detection in destained urine slides with combined analysis of standard cytology and CK-20 immunostaing.
    Soyuer I; Tokat F; Tasdemir A
    Acta Cytol; 2009; 53(3):357-60. PubMed ID: 19534284
    [No Abstract]   [Full Text] [Related]  

  • 10. [An unusual variant of urothelial carcinoma: the "nested variant of urothelial carcinoma." Report of two cases].
    Badoual C; Bergemer-Fouquet AM; Renjard L; Lefrancq T; Lesourd B; Belhiba H; Fetissof F; Vieillefond A
    Ann Pathol; 1999 Apr; 19(2):119-23. PubMed ID: 10349476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A diagnostic pitfall in the pathology of bladder tumors: the nested variant of urothelial carcinoma].
    Auriault ML; Comoz F; Bottet P; Bensadoun H
    Ann Pathol; 2000 Sep; 20(4):400-1. PubMed ID: 11015669
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathologic anatomy of superficial tumors of the bladder].
    Billerey C; Sibony M; Gattegno B; Chopin D
    Prog Urol; 2001 Nov; 11(5):805-63. PubMed ID: 11769082
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
    Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bladder tumor histo-seminar - case 4: Urinary cytology. Atypical urothelial cells of undetermined significance (AUC-US) or "atypical urothelial cells" (AUC of the Paris classification)].
    Piaton E
    Ann Pathol; 2016 Dec; 36(6):386-389. PubMed ID: 27838081
    [No Abstract]   [Full Text] [Related]  

  • 15. [New information in the classification of urothelial tumors of the bladder].
    Guillou L
    Ann Pathol; 1999; 19(5 Suppl):S103-7. PubMed ID: 10599468
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

  • 19. Polyomavirus infection and urothelial carcinoma.
    Loghavi S; Bose S
    Diagn Cytopathol; 2011 Jul; 39(7):531-5. PubMed ID: 20891007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.
    Feil G; Wechsel HW; Nelde HJ; Bichler KH
    Anticancer Res; 1999; 19(4A):2591-7. PubMed ID: 10470200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.